Immediate Impact
56 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Ronda Copher being referenced
Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ronda Copher | 126 | 31 | 56 | 256 | 235 | 51 | 789 | |
| Carolyn Harley | 178 | 43 | 43 | 138 | 88 | 33 | 948 | |
| Ana Macedo | 138 | 14 | 13 | 162 | 88 | 65 | 947 | |
| Jérémie Lebrec | 128 | 5 | 11 | 192 | 54 | 53 | 784 | |
| Anna J. Stevenson | 38 | 2 | 1 | 87 | 147 | 43 | 873 | |
| Christina Grant | 79 | 9 | 20 | 137 | 158 | 42 | 729 | |
| Yakir Rottenberg | 413 | 20 | 51 | 65 | 62 | 78 | 979 | |
| Jimmy Hwang | 257 | 12 | 8 | 37 | 181 | 37 | 846 | |
| Martti Arffman | 125 | 4 | 3 | 114 | 61 | 81 | 936 | |
| Linda Abetz‐Webb | 64 | 97 | 111 | 100 | 120 | 40 | 784 | |
| Jan Zeidler | 34 | 30 | 32 | 166 | 53 | 75 | 803 |
All Works
Loading papers...